Factors affecting healing time of postoperative pancreatic fistula in patients undergoing pancreaticoduodenectomy.
intraoperative blood loss
modified Blumgart anastomosis
pancreatic fistula
Journal
Molecular and clinical oncology
ISSN: 2049-9450
Titre abrégé: Mol Clin Oncol
Pays: England
ID NLM: 101613422
Informations de publication
Date de publication:
Apr 2019
Apr 2019
Historique:
received:
19
11
2018
accepted:
20
02
2019
entrez:
2
4
2019
pubmed:
2
4
2019
medline:
2
4
2019
Statut:
ppublish
Résumé
Clinically-relevant postoperative pancreatic fistula (CR-POPF) is one of the most serious complications following pancreaticoduodenectomy. While many investigators have studied risk factors for the development of CR-POPF, few studies have focused on time needed for CR-POPF healing in patients who develop this complication. The present study enrolled 38 cases in whom CR-POPF developed following pancreaticoduodenectomy (24.1%) out of 158 cases receiving treatment with pancreaticoduodenectomy between 2009 and 2017 for periampullary diseases. CR-POPF healing time, was defined as the length of time from the day of pancreaticoduodenectomy to the day when intraabdominal drainage tubes used for CR-POPF treatment were removed, were assessed and factors affecting the healing time were investigated. The mean CR-POPF healing time was 40.2±21.7 days (median; 35 days, range; 10-110 days). Univariate analysis demonstrated a significant relationship between CP-POPE healing time and sex, intraoperative blood loss, and type of pancreaticojejunostomy procedure. Multivariate Cox regression analysis using these factors revealed that intraoperative blood loss and type of pancreaticojejunostomy procedure were significant independent factors for the length of CR-POPF healing time. CR-POPF healing time following pancreaticoduodenectomy was 40.2±21.7 days on average (median, 35 days; range 10-110 days). Intraoperative blood loss and type of pancreaticojejunostomy procedure were identified as significant independent factors associated with the healing time. These results will help with earlier recovery from CR-POPF.
Identifiants
pubmed: 30931113
doi: 10.3892/mco.2019.1812
pii: MCO-0-0-1812
pmc: PMC6425506
doi:
Types de publication
Journal Article
Langues
eng
Pagination
435-440Références
J Hepatobiliary Pancreat Surg. 2001;8(3):230-7
pubmed: 11455485
Br J Surg. 2005 Sep;92(9):1117-23
pubmed: 15931656
Ann Surg. 2007 Sep;246(3):425-33; discussion 433-5
pubmed: 17717446
Surgery. 2010 Jul;148(1):15-23
pubmed: 20138325
J Am Coll Surg. 2010 Oct;211(4):510-21
pubmed: 20801693
J Hepatobiliary Pancreat Sci. 2011 Jul;18(4):601-8
pubmed: 21491103
J Gastrointest Surg. 2012 Mar;16(3):518-23
pubmed: 22083531
Ann Surg. 2012 Jul;256(1):139-45
pubmed: 22609844
Ann Surg. 2013 Mar;257(3):512-9
pubmed: 23241871
J Gastrointest Surg. 2014 Jun;18(6):1108-15
pubmed: 24733259
World J Gastroenterol. 2015 Feb 14;21(6):1872-9
pubmed: 25684954
BMC Surg. 2015 Mar 26;15:34
pubmed: 25887526
J Am Coll Surg. 2015 Sep;221(3):689-98
pubmed: 26296680
Lancet. 2016 Jul 16;388(10041):248-57
pubmed: 27265347
World J Gastroenterol. 2016 Sep 14;22(34):7797-805
pubmed: 27678363
Surgery. 2017 Mar;161(3):584-591
pubmed: 28040257
Lancet. 2017 Mar 11;389(10073):1011-1024
pubmed: 28129987
J Hepatobiliary Pancreat Sci. 2017 May;24(5):243-251
pubmed: 28196308
Nihon Geka Gakkai Zasshi. 1984 Sep;85(9):1001-5
pubmed: 6438478